An oral dosage form

An oral dosage form comprises a therapeutically active composition containing at least one omega-3-polyunsaturated fatty acid (PUFA), which oral dosage form has an outer surface comprising medicated print, where the medicated print comprises a hypolipidaemic drug. Preferably, the hypolipidaemic drug is a statin, such as atorvastatin, or a fibrate. The fatty acid may comprise 5,8,11,14,17-eicosapentaenoic acid (EPA) and 4,7,10,13,16,19-docosahexaenoic acid (DHA). The dosage form may be used in the treatment or prevention of cardiovascular disease, or in the prevention or treatment of hyperlipidaemia. The medicated print may be a medicated ink printed onto an outer surface of the oral dosage by inkject printing.